Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

The use of targeted agents in the treatment of metastatic colorectal cancer (CRC) has improved patient outcomes. Anti-epidermal growth factor receptor (anti-EGFR) agents (cetuximab and panitumumab) and antiangiogenic molecules (bevacizumab, regorafeninb, ramucirumab, and aflibercept) have been succe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Bignucolo, Alessia, De Mattia, Elena, Cecchin, Erika, Roncato, Rossana, Toffoli, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536012/
https://ncbi.nlm.nih.gov/pubmed/28708103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18071522
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki